These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38880645)

  • 1. Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment.
    Pukhalskaia TV; Yurakova TR; Bogdanova DA; Demidov ON
    Biochemistry (Mosc); 2024 May; 89(5):839-852. PubMed ID: 38880645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
    Du M; Sun L; Guo J; Lv H
    Pharmacol Res; 2024 Jun; 204():107198. PubMed ID: 38692466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial interaction and functional status of CD68
    Liu X; Zhang Z; Yuan J; Yu J; Chen D
    Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting.
    Fiani ML; Barreca V; Sargiacomo M; Ferrantelli F; Manfredi F; Federico M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.
    Malik S; Sureka N; Ahuja S; Aden D; Zaheer S; Zaheer S
    Cell Biol Int; 2024 Oct; 48(10):1406-1449. PubMed ID: 39054741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment.
    Deng Y; Chen Q; Yang X; Sun Y; Zhang B; Wei W; Deng S; Meng J; Hu Y; Wang Y; Zhang Z; Wen L; Huang F; Wan C; Yang K
    Theranostics; 2024; 14(3):1224-1240. PubMed ID: 38323313
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanistic studies of tumor-associated macrophage immunotherapy.
    Cao J; Liu C
    Front Immunol; 2024; 15():1476565. PubMed ID: 39403370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
    Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-based cancer immunotherapy: Challenges and opportunities.
    Bai H; Feng L; Schmid F
    Exp Cell Res; 2024 Sep; 442(1):114198. PubMed ID: 39103071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Associated Macrophages in Tumor Immunity.
    Pan Y; Yu Y; Wang X; Zhang T
    Front Immunol; 2020; 11():583084. PubMed ID: 33365025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls.
    Salmaninejad A; Layeghi SM; Falakian Z; Golestani S; Kobravi S; Talebi S; Yousefi M
    Clin Exp Med; 2024 Jul; 24(1):156. PubMed ID: 39003350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
    Li L; Tian Y
    Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials.
    Zhang W; Wang M; Ji C; Liu X; Gu B; Dong T
    Biomed Pharmacother; 2024 Aug; 177():116930. PubMed ID: 38878638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapies.
    Vizcaino Castro A; Daemen T; Oyarce C
    Immunol Lett; 2024 Jun; 267():106864. PubMed ID: 38705481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
    Wang Y; Wang D; Yang L; Zhang Y
    Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
    Su P; Li O; Ke K; Jiang Z; Wu J; Wang Y; Mou Y; Jin W
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38695252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.